Cassava Sciences | Kostnadene For Salg



Cost Of Sales Endring Dato
Abbott USD 4.94B 246M 2024-12
Amgen USD 3.11B 198M 2024-12
Biogen USD 583.5M 55.2M 2024-12
Cassava Sciences 97.2K 16.13M 2024-06
Eisai JPY 45.94B 3.42B 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Geron 783K 327K 2024-12
J&J USD 7.11B 151M 2024-12
Merck USD 3.71B 181M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 5.65B 781M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12



Cassava Sciences Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.